Citrobacter rodentium infection causes iNOS-independent intestinal epithelial dysfunction in mice

Canadian Journal of Physiology and Pharmacology

Volumn 84, Issue 12, 2006, Pages 1301-1312

  Skinn, Andrew C ^a   Vergnolle, Nathalie ^a   Zamuner, Stella R ^a   Wallace, John L ^a   Cellars, Laurie ^a   MacNaughton, Wallace K ^a   Sherman, Philip M ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Colon; Epithelium; Infection; Inflammation; Ion transport; Nitric oxide

Indexed keywords

CARBACHOL; CYCLOOXYGENASE 2; FORSKOLIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MYELOPEROXIDASE; ROFECOXIB;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BACTERIAL TRANSLOCATION; CITROBACTER RODENTIUM; COLITIS; COLON DISEASE; COLON INJURY; COLON MUCOSA; COLON SECRETION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; EPITHELIUM HYPERPLASIA; HISTOPATHOLOGY; INTESTINE EPITHELIUM; ION TRANSPORT; MALE; MOUSE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; WESTERN BLOTTING; WILD TYPE;

ANIMALS; BACTERIAL TRANSLOCATION; CARBACHOL; CELL MEMBRANE PERMEABILITY; CHOLINERGIC AGONISTS; CITROBACTER RODENTIUM; COLITIS; COLON; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; ENTEROBACTERIACEAE INFECTIONS; HYPERPLASIA; INTESTINAL MUCOSA; INTESTINAL SECRETIONS; ION TRANSPORT; LACTONES; LYMPH NODES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; PEROXIDASE; SULFONES; TIME FACTORS;

EID: 34248215286     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y06-086     Document Type: Article

References (33)

1. Asfaha, S., Bell, C.J., Wallace, J.L., and MacNaughton, W.K. 1999. Prolonged colonic epithelial hyporesponsiveness after colitis: role of inducible nitric oxide synthase. Am. J. Physiol. 276: G703-G710.
2. Asfaha, S., MacNaughton, W.K., Appleyard, C.B., Chadee, K., and Wallace, J.L. 2001. Persistent epithelial dysfunction and bacterial translocation after resolution of intestinal inflammation. Am. J. Physiol. 281: G635-G644.
3. Barthold, S.W., Coleman, G.L., Jacoby, R.O., Livestone, E.M., and Jonas, A.M. 1978. Transmissible murine colonic hyperplasia. Vet. Pathol. 15: 223-236.
4. Berkes, J., Viswanathan, V.K., Savkovic, S.D., and Hecht, G. 2003. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut, 52: 439-451. doi:10.1136/gut.52.3.439.
5. Bry, L., Brigl, M., and Brenner, M.B. 2006. CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium. Infect. Immun. 74: 673-681. doi:10.1128/IAI.74.1.673-681.2006.
6. Carey, H.V., Cooke, H.J., and Zafirova, M. 1985. Mucosal responses evoked by stimulation of the ganglion cell somas in the submucosal plexus of the guinea-pig ileum. J. Physiol. 364: 69-79.
7. Cenac, N., Coelho, A.M., Nguyen, C., Compton, S., Andrade-Gordon, P., MacNaughton, W.K., et al. 2002. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am. J. Pathol. 161: 1903-1915.
8. Dickinson, E., Tuncer, R., Nadler, E., Boyle, P., Alber, S., Watkins, S., and Ford, H. 1999. NOX, a novel nitric oxide scavenger, reduces bacterial translocation in rats after endotoxin challenge. Am. J. Physiol. 277: G1281-G1287.
9. Elson, C.O., Cong, Y., Lorenz, R., and Weaver, C.T. 2004a. New developments in experimental models of inflammatory bowel disease. Curr. Opin. Gastroenterol. 20: 360-367.
10. Elson, C.O., Konrad, A., Cong, Y., and Weaver, C.T. 2004b. Gene disruption and immunity in experimental colitis. Inflamm. Bowel Dis. 10(Suppl. 1): S25-S28.
11. Freeman, S.L., and MacNaughton, W.K. 2000. Ionizing radiation induces iNOS-mediated epithelial dysfunction in the absence of an inflammatory response. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G243-G250.
12. Gobert, A.P., Cheng, Y., Akhtar, M., Mersey, B.D., Blumberg, D.R., Cross, R.K., et al. 2004. Protective role of arginase in a mouse model of colitis. J. Immunol. 173: 2109-2117.
13. Green, C.L., Ho, W., Sharkey, K.A., and McKay, D.M. 2004. Dextran sodium sulfate-induced colitis reveals nicotinic modulation of ion transport via iNOS-derived nitric oxide. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G706-G714. doi:10.1152/ajpgi. 00076.2004.
14. Hansen, K.K., Sherman, P.M., Cellars, L., Andrade-Gordon, P., Pan, Z., Baruch, A., et al. 2005. A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis. Proc. Natl. Acad. Sci. U.S.A. 102: 8363-8368. doi:10.1073/pnas.0409535102.
15. Hubel, K.A., and Renquist, K.S. 1990. Ion transport in normal and inflamed human jejunum in vitro. Changes with electrical field stimulation and theophylline. Dig. Dis. Sci. 35: 815-820. doi:10.1007/BF01536793.
16. Johnson-Henry, K.C., Nadjafi, M., Avitzur, Y., Mitchell, D.J., Ngan, B.Y., Galindo-Mata, E., Jones, N.L., and Sherman, P.M. 2005. Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics. J. Infect. Dis. 191: 2106-2117. doi:10.1086/430318.
17. Kaper, J.B., Nataro, J.P., and Mobley, H.L. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2: 123-140. doi:10.1038/nrmicro818.
18. Luperchio, S.A., Newman, J.V., Dangler, C.A., Schrenzel, M.D., Brenner, D.J., Steigerwalt, A.G., and Schauer, D.B. 2000. Citrobacter rodentium, the causative agent of transmissible murine colonic hyperplasia, exhibits clonality: synonymy of C. rodentium and mouse-pathogenic Escherichia coli. J. Clin. Microbiol. 38: 4343-4350.
19. MacNaughton, W.K., Lowe, S.S., and Cushing, K. 1998. Role of nitric oxide in inflammation-induced suppression of secretion in a mouse model of acute colitis. Am. J. Physiol. 275: G1353-G1360.
20. Martin, A.R., Villegas, I., and Alarcon de la Lastra, C. 2005. The COX-2 inhibitor, rofecoxib, ameliorates dextran sulphate sodium induced colitis in mice. Inflamm. Res. 54: 145-151. doi:10. 1007/s00011-004-1337-2.
21. Miki, K., Moore, D.J., Butler, R.N., Southcott, E., Couper, R.T., and Davidson, G.P. 1998. The sugar permeability test reflects disease activity in children and adolescents with inflammatory bowel disease. J. Pediatr. 133: 750-754.
22. Mundy, R., MacDonald, T.T., Dougan, G., Frankel, G., and Wiles, S. 2005. Citrobacter rodentium of mice and man. Cell. Microbiol. 7: 1697-1706. doi:10.1111/j.1462-5822.2005.00625.x.
23. Resta-Lenert, S., and Barrett, K.E. 2002. Enteroinvasive bacteria alter barrier and transport properties of human intestinal epithelium: role of iNOS and COX-2. Gastroenterology, 122: 1070-1087.
24. Sandle, G.I., Higgs, N., Crowe, P., Marsh, M.N., Venkatesan, S., and Peters, T.J. 1990. Cellular basis for defective electrolyte transport in inflamed human colon. Gastroenterology, 99: 97-105.
25. Savkovic, S.D., Villanueva, J., Turner, J.R., Matkowskyj, K.A., and Hecht, G. 2005. Mouse model of enteropathogenic Escherichia coli infection. Infect. Immun. 73: 1161-1170. doi:10.1128/IAI.73.2.1161-1170. 2005.
26. Sayer, B., Lu, J., Green, C., Soderholm, J.D., Akhtar, M., and McKay, D.M. 2002. Dextran sodium sulphate-induced colitis perturbs muscarinic cholinergic control of colonic epithelial ion transport. Br. J. Pharmacol. 135: 1794-1800. doi:10.1038/sj.bjp.0704633.
27. Schauer, D.B., and Falkow, S. 1993. The eae gene of Citrobacter freundii biotype 4280 is necessary for colonization in transmissible murine colonic hyperplasia. Infect. Immun. 61: 4654-4661.
28. Schauer, D.B., Zabel, B.A., Pedraza, I.F., O'Hara, C.M., Steigerwalt, A.G., and Brenner, D.J. 1995. Genetic and biochemical characterization of Citrobacter rodentium sp. nov. J. Clin. Microbiol. 33: 2064-2068.
29. Vallance, B.A., and Finlay, B.B. 2000. Exploitation of host cells by enteropathogenic Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 97: 8799-8806. doi:10.1073/pnas.97.16.8799.
30. Vallance, B.A., Deng, W., De Grado, M., Chan, C., Jacobson, K., and Finlay, B.B. 2002. Modulation of inducible nitric oxide synthase expression by the attaching and effacing bacterial pathogen Citrobacter rodentium in infected mice. Infect. Immun. 70: 6424-6435. doi:10.1128/IAI.70.11.6424- 6435.2002.
31. Wallace, J.L., Keenan, C.M., Gale, D., and Shoupe, T.S. 1992. Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis. Gastroenterology, 102: 18-27.
32. Zamuner, S.R., Warrier, N., Buret, A.G., MacNaughton, W.K., and Wallace, J.L. 2003. Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction. Gut, 52: 1714-1720. doi:10.1136/gut.52.12.1714.
33. Zareie, M., Johnson-Henry, K.C., Jury, J., Yang, P.C., Ngan, B.Y., McKay, D.M., et al. 2006. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut, 55: 1553-1560. doi:10.1136/ gut.2005.080739.